These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways. Huang Y; Wang Y; Wang Y; Wang N; Duan Q; Wang S; Liu M; Bilal MA; Zheng Y J Invest Dermatol; 2022 Feb; 142(2):303-313.e9. PubMed ID: 34358528 [TBL] [Abstract][Full Text] [Related]
4. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of lysophosphatidylcholine acyltransferase 1 (LPCAT1) is linked to poor prognosis in breast cancer. Lebok P; von Hassel A; Meiners J; Hube-Magg C; Simon R; Höflmayer D; Hinsch A; Dum D; Fraune C; Göbel C; Möller K; Sauter G; Jacobsen F; Büscheck F; Prien K; Krech T; Krech RH; von der Assen A; Wölber L; Witzel I; Schmalfeldt B; Geist S; Paluchoswski P; Wilke C; Heilenkötter U; Terracciano L; Müller V; Wilczak W; Burandt EC Aging (Albany NY); 2019 Sep; 11(18):7796-7804. PubMed ID: 31533087 [TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine acyltransferase 1 controls mitochondrial reactive oxygen species generation and survival of retinal photoreceptor cells. Nagata K; Hishikawa D; Sagara H; Saito M; Watanabe S; Shimizu T; Shindou H J Biol Chem; 2022 Jun; 298(6):101958. PubMed ID: 35452679 [TBL] [Abstract][Full Text] [Related]
7. Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice. Li Z; Jiang H; Ding T; Lou C; Bui HH; Kuo MS; Jiang XC Gastroenterology; 2015 Nov; 149(6):1519-29. PubMed ID: 26226572 [TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor. Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864 [TBL] [Abstract][Full Text] [Related]
10. Phospholipid Remodeling in Physiology and Disease. Wang B; Tontonoz P Annu Rev Physiol; 2019 Feb; 81():165-188. PubMed ID: 30379616 [TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma. Du Y; Wang Q; Zhang X; Wang X; Qin C; Sheng Z; Yin H; Jiang C; Li J; Xu T J Exp Clin Cancer Res; 2017 May; 36(1):66. PubMed ID: 28494778 [TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) upregulation in breast carcinoma contributes to tumor progression and predicts early tumor recurrence. Abdelzaher E; Mostafa MF Tumour Biol; 2015 Jul; 36(7):5473-83. PubMed ID: 25683484 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of Lysophosphatidylcholine Acyltransferase 1 and Concomitant Lipid Alterations in Gastric Cancer. Uehara T; Kikuchi H; Miyazaki S; Iino I; Setoguchi T; Hiramatsu Y; Ohta M; Kamiya K; Morita Y; Tanaka H; Baba S; Hayasaka T; Setou M; Konno H Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S206-13. PubMed ID: 25752890 [TBL] [Abstract][Full Text] [Related]
14. Frequent amplification of AIB1, a critical oncogene modulating major signaling pathways, is associated with poor survival in gastric cancer. Shi J; Liu W; Sui F; Lu R; He Q; Yang Q; Lv H; Shi B; Hou P Oncotarget; 2015 Jun; 6(16):14344-59. PubMed ID: 25970779 [TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. Mansilla F; da Costa KA; Wang S; Kruhøffer M; Lewin TM; Orntoft TF; Coleman RA; Birkenkamp-Demtröder K J Mol Med (Berl); 2009 Jan; 87(1):85-97. PubMed ID: 18974965 [TBL] [Abstract][Full Text] [Related]
16. Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion. Rong X; Wang B; Dunham MM; Hedde PN; Wong JS; Gratton E; Young SG; Ford DA; Tontonoz P Elife; 2015 Mar; 4():. PubMed ID: 25806685 [TBL] [Abstract][Full Text] [Related]
17. Oncogenes and signal transduction. Wong AJ; Croce CM Hosp Pract (Off Ed); 1993 Jul; 28(7):128-32, 136-8, 141. PubMed ID: 8325909 [TBL] [Abstract][Full Text] [Related]